jueves, 4 de febrero de 2021

Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH)

Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH)

No hay comentarios:

Publicar un comentario